"The acquisition of Vectura reflects our commitment to advancing industry-leading medical capabilities for our customers," said Joe Nelligan, CEO, Molex, which acquired Phillips Medisize in 2016.

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...

The transaction includes Vectura’s proprietary technology and combination product development expertise in dry powder inhalers (DPI), including the Lever Operated Multi-dose Inhaler (LOMI) and ...

Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRx™, today announced the ...

Wildfires are storming into urban areas more frequently, and toxins in homes and cars are increasing cancer risk for ...

Wildfires are storming into urban areas more frequently, and toxins in homes and cars are increasing cancer risk for ...

Analyst Serge Belanger of Needham maintained a Buy rating on Liquidia Technologies (LQDA – Research Report), retaining the price target of ...

The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

This form is inhaled using a nebulizer ... information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific ...